Eagle Pharmaceuticals to Present at Piper Jaffray 28th Annual Healthcare Conference

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ: EGRX) today announced that Scott Tarriff, President and Chief Executive Officer, and David Riggs, Chief Financial Officer, will present at the Piper Jaffray 28th Annual Healthcare Conference as follows:

The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161121005285/en/

Investor Relations
In-Site Communications, Inc.
Lisa M. Wilson, 212-452-2793
President

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• DTC Group Joins AI Expo Thailand 2026 as Partner, Speaker
• Deep Fission Rejects Distortions in Short-Seller Report
• New Crypto: AlphaPepe Presale Crosses $2.8M Raised While Bitcoin Price Prediction Targets $150,000